CollPlant Biotechnologies (CLGN) Receivables - Other (2017 - 2019)

CollPlant Biotechnologies has reported Receivables - Other for 3 years, with the latest figure at $270000.0 in Q4 2019.

• For the quarter ending Q4 2019, Receivables - Other fell 19.16% year-over-year to $270000.0; the trailing twelve-month figure through Dec 2019 stood at $270000.0 (down 19.16% YoY), and the FY2019 full-year result was $270000.0, down 19.16% from the prior year.
• Receivables - Other for Q4 2019 stood at $270000.0, down from $334000.0 in the prior quarter.
• The five-year high for Receivables - Other was $1.0 million in Q4 2017, with the low at $270000.0 in Q4 2019.
• Historically, Receivables - Other has averaged $542000.0 across 3 years, with a median of $334000.0 in 2018.
• Annual changes were most pronounced in 2018 — Receivables - Other slumped 67.32% — and 2019, when it decreased 19.16%.
• CollPlant Biotechnologies' Receivables - Other stood at $1.0 million in 2017, then tumbled by 67.32% to $334000.0 in 2018, then retreated by 19.16% to $270000.0 in 2019.
• The last three Receivables - Other figures came in at $270000.0 (Q4 2019), $334000.0 (Q4 2018), and $1.0 million (Q4 2017), per Business Quant data.